EXHIBIT 10.1 This TENTH AMENDMENT TO CREDIT AGREEMENT, dated as of November 4, 2025 (this "Amendment"), is entered into by and among (a) PURECYCLE TECHNOLOGIES, INC., a Delaware corporation (the "Borrower"), (b) PURECYCLE TECHNOLOGIES HOLDINGS CORP., a Delaware Corporation ("Holdings"), (c) PURECYCLE TECHNOLOGIES, LLC, a Delaware limited liability company ("PureCycle LLC"), (d) PURECYCLE AUGUSTA, LLC, a Delaware limited liability company ("PureCycle Augusta" and, together with Holdings and PureCycle LLC, co ...

EXHIBIT 10.1 TENTH AMENDMENT TO CREDIT AGREEMENT This TENTH AMENDMENT TO CREDIT AGREEMENT, dated as of November 4, 2025 (this "Amendment"), is entered into by and among (a) PURECYCLE TECHNOLOGIES, INC., a Delaware corporation (the "Borrower"), (b) PURECYCLE TECHNOLOGIES HOLDINGS CORP., a Delaware Corporation ("Holdings"), (c) PURECYCLE TECHNOLOGIES, LLC, a Delaware limited liability company ("PureCycle LLC"), (d) PURECYCLE AUGUSTA, LLC, a Delaware limited liability company ("PureCycle Augusta" and, together ...

EXHIBIT 10.1 TENTH AMENDMENT TO CREDIT AGREEMENT This TENTH AMENDMENT TO CREDIT AGREEMENT, dated as of November 4, 2025 (this "Amendment"), is entered into by and among (a) PURECYCLE TECHNOLOGIES, INC., a Delaware corporation (the "Borrower"), (b) PURECYCLE TECHNOLOGIES HOLDINGS CORP., a Delaware Corporation ("Holdings"), (c) PURECYCLE TECHNOLOGIES, LLC, a Delaware limited liability company ("PureCycle LLC"), (d) PURECYCLE AUGUSTA, LLC, a Delaware limited liability company ("PureCycle Augusta" and, together ...

Exhibit 99.1 PRESS RELEASE Prothena Reports Third Quarter 2025 Financial Results and Business Highlights DUBLIN, Ireland, November 6, 2025 -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today reported financial results for the third quarter and first nine months of 2025 and provided business highlights. "We are pleased with the advancement of our late-stage partnered clini ...

STEPSTONE GROUP REPORTS SECOND QUARTER FISCAL YEAR 2026 RESULTS NEW YORK, November 6, 2025 – StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended September 30, 2025. This represents results for the second quarter of the fiscal year ending March 31, 2026. The Board of Directors of the Company has declared a quarterly cash dividend of $0.28 per share of Cla ...

Exhibit 99.1 Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results Oncology Program • Phase 1 open-label trial of PLN-101095 in solid tumors has completed enrollment. PLN-101095 is an oral, small molecule, dual selective inhibitor of αvβ8 and αvβ1 integrins designed to overcome checkpoint resistance by blocking TGF-β activation in the tumor microenvironment. The Phase 1 open-label, dose-escalation trial of PLN-101095 as monotherapy and in combination with pembrolizum ...

Exhibit 99.1 The Joint Corp. Reports Third Quarter 2025 Financial Results - Grew Revenue 6%, Compared to Third Quarter 2024 - - Board authorizes an additional $12 million for share repurchases - SCOTTSDALE, Ariz., November 6, 2025 – The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financial information for the quarter ended September 30, 2025. The following figures represent continuing operations unless otherwise st ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-30347 CURIS, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 04-3505116 (State or ...

Press Release For Immediate Release Investor Relations Contact: Media Relations Contact: Will Davis Stacey Giglio +1 917-519-6994 +1 321-525-4607 wdavis@gogoair.com sgiglio@gogoair.com Gogo Announces Third Quarter 2025 Results Total Revenue of $223.6 million, up 122% Year-over-Year; Service Revenue of $190.0 million, up 132% Year-over-Year Net Loss of $1.9 million, which includes a $15 million pre-tax acquisition-related earn-out accrual Adjusted EBITDA(1) of $56.2 million, up 61% Year-over-Year Over 200 Ye ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 —————————————————————— FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35897 Voya Financial, Inc. | (Exact name of registrant as specified in its charter) | | | | | --- | --- | --- | ...